Global Cholera Vaccines Oral Live Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Cholera Vaccines Oral Live market size was valued at USD 87 million in 2023 and is forecast to a readjusted size of USD 137.6 million by 2030 with a CAGR of 6.7% during review period.
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
The Global Info Research report includes an overview of the development of the Cholera Vaccines Oral Live industry chain, the market status of Prevention (Euvichol- Plus, DUKORAL), Emergency Response (Euvichol- Plus, DUKORAL), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cholera Vaccines Oral Live.
Regionally, the report analyzes the Cholera Vaccines Oral Live markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cholera Vaccines Oral Live market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cholera Vaccines Oral Live market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cholera Vaccines Oral Live industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Euvichol- Plus, DUKORAL).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cholera Vaccines Oral Live market.
Regional Analysis: The report involves examining the Cholera Vaccines Oral Live market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cholera Vaccines Oral Live market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cholera Vaccines Oral Live:
Company Analysis: Report covers individual Cholera Vaccines Oral Live manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cholera Vaccines Oral Live This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Prevention, Emergency Response).
Technology Analysis: Report covers specific technologies relevant to Cholera Vaccines Oral Live. It assesses the current state, advancements, and potential future developments in Cholera Vaccines Oral Live areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cholera Vaccines Oral Live market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cholera Vaccines Oral Live market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Cholera Vaccines Oral Live product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cholera Vaccines Oral Live, with price, sales, revenue and global market share of Cholera Vaccines Oral Live from 2019 to 2024.
Chapter 3, the Cholera Vaccines Oral Live competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cholera Vaccines Oral Live breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Cholera Vaccines Oral Live market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cholera Vaccines Oral Live.
Chapter 14 and 15, to describe Cholera Vaccines Oral Live sales channel, distributors, customers, research findings and conclusion.
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
The Global Info Research report includes an overview of the development of the Cholera Vaccines Oral Live industry chain, the market status of Prevention (Euvichol- Plus, DUKORAL), Emergency Response (Euvichol- Plus, DUKORAL), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cholera Vaccines Oral Live.
Regionally, the report analyzes the Cholera Vaccines Oral Live markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cholera Vaccines Oral Live market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cholera Vaccines Oral Live market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cholera Vaccines Oral Live industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Euvichol- Plus, DUKORAL).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cholera Vaccines Oral Live market.
Regional Analysis: The report involves examining the Cholera Vaccines Oral Live market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cholera Vaccines Oral Live market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cholera Vaccines Oral Live:
Company Analysis: Report covers individual Cholera Vaccines Oral Live manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cholera Vaccines Oral Live This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Prevention, Emergency Response).
Technology Analysis: Report covers specific technologies relevant to Cholera Vaccines Oral Live. It assesses the current state, advancements, and potential future developments in Cholera Vaccines Oral Live areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cholera Vaccines Oral Live market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cholera Vaccines Oral Live market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Euvichol- Plus
- DUKORAL
- Shanchol
- Others
- Prevention
- Emergency Response
- PaxVax
- Sanofi
- Valneva
- EuBiologics
- Shanghai United Cell Biotechnology
- Vabiotech
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Cholera Vaccines Oral Live product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cholera Vaccines Oral Live, with price, sales, revenue and global market share of Cholera Vaccines Oral Live from 2019 to 2024.
Chapter 3, the Cholera Vaccines Oral Live competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cholera Vaccines Oral Live breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Cholera Vaccines Oral Live market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cholera Vaccines Oral Live.
Chapter 14 and 15, to describe Cholera Vaccines Oral Live sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Cholera Vaccines Oral Live
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cholera Vaccines Oral Live Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Euvichol- Plus
1.3.3 DUKORAL
1.3.4 Shanchol
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Cholera Vaccines Oral Live Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Prevention
1.4.3 Emergency Response
1.5 Global Cholera Vaccines Oral Live Market Size & Forecast
1.5.1 Global Cholera Vaccines Oral Live Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Cholera Vaccines Oral Live Sales Quantity (2019-2030)
1.5.3 Global Cholera Vaccines Oral Live Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 PaxVax
2.1.1 PaxVax Details
2.1.2 PaxVax Major Business
2.1.3 PaxVax Cholera Vaccines Oral Live Product and Services
2.1.4 PaxVax Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 PaxVax Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Cholera Vaccines Oral Live Product and Services
2.2.4 Sanofi Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments/Updates
2.3 Valneva
2.3.1 Valneva Details
2.3.2 Valneva Major Business
2.3.3 Valneva Cholera Vaccines Oral Live Product and Services
2.3.4 Valneva Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Valneva Recent Developments/Updates
2.4 EuBiologics
2.4.1 EuBiologics Details
2.4.2 EuBiologics Major Business
2.4.3 EuBiologics Cholera Vaccines Oral Live Product and Services
2.4.4 EuBiologics Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 EuBiologics Recent Developments/Updates
2.5 Shanghai United Cell Biotechnology
2.5.1 Shanghai United Cell Biotechnology Details
2.5.2 Shanghai United Cell Biotechnology Major Business
2.5.3 Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Product and Services
2.5.4 Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Shanghai United Cell Biotechnology Recent Developments/Updates
2.6 Vabiotech
2.6.1 Vabiotech Details
2.6.2 Vabiotech Major Business
2.6.3 Vabiotech Cholera Vaccines Oral Live Product and Services
2.6.4 Vabiotech Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Vabiotech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CHOLERA VACCINES ORAL LIVE BY MANUFACTURER
3.1 Global Cholera Vaccines Oral Live Sales Quantity by Manufacturer (2019-2024)
3.2 Global Cholera Vaccines Oral Live Revenue by Manufacturer (2019-2024)
3.3 Global Cholera Vaccines Oral Live Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Cholera Vaccines Oral Live by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Cholera Vaccines Oral Live Manufacturer Market Share in 2023
3.4.2 Top 6 Cholera Vaccines Oral Live Manufacturer Market Share in 2023
3.5 Cholera Vaccines Oral Live Market: Overall Company Footprint Analysis
3.5.1 Cholera Vaccines Oral Live Market: Region Footprint
3.5.2 Cholera Vaccines Oral Live Market: Company Product Type Footprint
3.5.3 Cholera Vaccines Oral Live Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Cholera Vaccines Oral Live Market Size by Region
4.1.1 Global Cholera Vaccines Oral Live Sales Quantity by Region (2019-2030)
4.1.2 Global Cholera Vaccines Oral Live Consumption Value by Region (2019-2030)
4.1.3 Global Cholera Vaccines Oral Live Average Price by Region (2019-2030)
4.2 North America Cholera Vaccines Oral Live Consumption Value (2019-2030)
4.3 Europe Cholera Vaccines Oral Live Consumption Value (2019-2030)
4.4 Asia-Pacific Cholera Vaccines Oral Live Consumption Value (2019-2030)
4.5 South America Cholera Vaccines Oral Live Consumption Value (2019-2030)
4.6 Middle East and Africa Cholera Vaccines Oral Live Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Cholera Vaccines Oral Live Sales Quantity by Type (2019-2030)
5.2 Global Cholera Vaccines Oral Live Consumption Value by Type (2019-2030)
5.3 Global Cholera Vaccines Oral Live Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Cholera Vaccines Oral Live Sales Quantity by Application (2019-2030)
6.2 Global Cholera Vaccines Oral Live Consumption Value by Application (2019-2030)
6.3 Global Cholera Vaccines Oral Live Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Cholera Vaccines Oral Live Sales Quantity by Type (2019-2030)
7.2 North America Cholera Vaccines Oral Live Sales Quantity by Application (2019-2030)
7.3 North America Cholera Vaccines Oral Live Market Size by Country
7.3.1 North America Cholera Vaccines Oral Live Sales Quantity by Country (2019-2030)
7.3.2 North America Cholera Vaccines Oral Live Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Cholera Vaccines Oral Live Sales Quantity by Type (2019-2030)
8.2 Europe Cholera Vaccines Oral Live Sales Quantity by Application (2019-2030)
8.3 Europe Cholera Vaccines Oral Live Market Size by Country
8.3.1 Europe Cholera Vaccines Oral Live Sales Quantity by Country (2019-2030)
8.3.2 Europe Cholera Vaccines Oral Live Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Cholera Vaccines Oral Live Market Size by Region
9.3.1 Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Cholera Vaccines Oral Live Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Cholera Vaccines Oral Live Sales Quantity by Type (2019-2030)
10.2 South America Cholera Vaccines Oral Live Sales Quantity by Application (2019-2030)
10.3 South America Cholera Vaccines Oral Live Market Size by Country
10.3.1 South America Cholera Vaccines Oral Live Sales Quantity by Country (2019-2030)
10.3.2 South America Cholera Vaccines Oral Live Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Cholera Vaccines Oral Live Market Size by Country
11.3.1 Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Cholera Vaccines Oral Live Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Cholera Vaccines Oral Live Market Drivers
12.2 Cholera Vaccines Oral Live Market Restraints
12.3 Cholera Vaccines Oral Live Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Cholera Vaccines Oral Live and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cholera Vaccines Oral Live
13.3 Cholera Vaccines Oral Live Production Process
13.4 Cholera Vaccines Oral Live Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cholera Vaccines Oral Live Typical Distributors
14.3 Cholera Vaccines Oral Live Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Cholera Vaccines Oral Live
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cholera Vaccines Oral Live Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Euvichol- Plus
1.3.3 DUKORAL
1.3.4 Shanchol
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Cholera Vaccines Oral Live Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Prevention
1.4.3 Emergency Response
1.5 Global Cholera Vaccines Oral Live Market Size & Forecast
1.5.1 Global Cholera Vaccines Oral Live Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Cholera Vaccines Oral Live Sales Quantity (2019-2030)
1.5.3 Global Cholera Vaccines Oral Live Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 PaxVax
2.1.1 PaxVax Details
2.1.2 PaxVax Major Business
2.1.3 PaxVax Cholera Vaccines Oral Live Product and Services
2.1.4 PaxVax Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 PaxVax Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Cholera Vaccines Oral Live Product and Services
2.2.4 Sanofi Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments/Updates
2.3 Valneva
2.3.1 Valneva Details
2.3.2 Valneva Major Business
2.3.3 Valneva Cholera Vaccines Oral Live Product and Services
2.3.4 Valneva Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Valneva Recent Developments/Updates
2.4 EuBiologics
2.4.1 EuBiologics Details
2.4.2 EuBiologics Major Business
2.4.3 EuBiologics Cholera Vaccines Oral Live Product and Services
2.4.4 EuBiologics Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 EuBiologics Recent Developments/Updates
2.5 Shanghai United Cell Biotechnology
2.5.1 Shanghai United Cell Biotechnology Details
2.5.2 Shanghai United Cell Biotechnology Major Business
2.5.3 Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Product and Services
2.5.4 Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Shanghai United Cell Biotechnology Recent Developments/Updates
2.6 Vabiotech
2.6.1 Vabiotech Details
2.6.2 Vabiotech Major Business
2.6.3 Vabiotech Cholera Vaccines Oral Live Product and Services
2.6.4 Vabiotech Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Vabiotech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CHOLERA VACCINES ORAL LIVE BY MANUFACTURER
3.1 Global Cholera Vaccines Oral Live Sales Quantity by Manufacturer (2019-2024)
3.2 Global Cholera Vaccines Oral Live Revenue by Manufacturer (2019-2024)
3.3 Global Cholera Vaccines Oral Live Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Cholera Vaccines Oral Live by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Cholera Vaccines Oral Live Manufacturer Market Share in 2023
3.4.2 Top 6 Cholera Vaccines Oral Live Manufacturer Market Share in 2023
3.5 Cholera Vaccines Oral Live Market: Overall Company Footprint Analysis
3.5.1 Cholera Vaccines Oral Live Market: Region Footprint
3.5.2 Cholera Vaccines Oral Live Market: Company Product Type Footprint
3.5.3 Cholera Vaccines Oral Live Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Cholera Vaccines Oral Live Market Size by Region
4.1.1 Global Cholera Vaccines Oral Live Sales Quantity by Region (2019-2030)
4.1.2 Global Cholera Vaccines Oral Live Consumption Value by Region (2019-2030)
4.1.3 Global Cholera Vaccines Oral Live Average Price by Region (2019-2030)
4.2 North America Cholera Vaccines Oral Live Consumption Value (2019-2030)
4.3 Europe Cholera Vaccines Oral Live Consumption Value (2019-2030)
4.4 Asia-Pacific Cholera Vaccines Oral Live Consumption Value (2019-2030)
4.5 South America Cholera Vaccines Oral Live Consumption Value (2019-2030)
4.6 Middle East and Africa Cholera Vaccines Oral Live Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Cholera Vaccines Oral Live Sales Quantity by Type (2019-2030)
5.2 Global Cholera Vaccines Oral Live Consumption Value by Type (2019-2030)
5.3 Global Cholera Vaccines Oral Live Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Cholera Vaccines Oral Live Sales Quantity by Application (2019-2030)
6.2 Global Cholera Vaccines Oral Live Consumption Value by Application (2019-2030)
6.3 Global Cholera Vaccines Oral Live Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Cholera Vaccines Oral Live Sales Quantity by Type (2019-2030)
7.2 North America Cholera Vaccines Oral Live Sales Quantity by Application (2019-2030)
7.3 North America Cholera Vaccines Oral Live Market Size by Country
7.3.1 North America Cholera Vaccines Oral Live Sales Quantity by Country (2019-2030)
7.3.2 North America Cholera Vaccines Oral Live Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Cholera Vaccines Oral Live Sales Quantity by Type (2019-2030)
8.2 Europe Cholera Vaccines Oral Live Sales Quantity by Application (2019-2030)
8.3 Europe Cholera Vaccines Oral Live Market Size by Country
8.3.1 Europe Cholera Vaccines Oral Live Sales Quantity by Country (2019-2030)
8.3.2 Europe Cholera Vaccines Oral Live Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Cholera Vaccines Oral Live Market Size by Region
9.3.1 Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Cholera Vaccines Oral Live Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Cholera Vaccines Oral Live Sales Quantity by Type (2019-2030)
10.2 South America Cholera Vaccines Oral Live Sales Quantity by Application (2019-2030)
10.3 South America Cholera Vaccines Oral Live Market Size by Country
10.3.1 South America Cholera Vaccines Oral Live Sales Quantity by Country (2019-2030)
10.3.2 South America Cholera Vaccines Oral Live Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Cholera Vaccines Oral Live Market Size by Country
11.3.1 Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Cholera Vaccines Oral Live Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Cholera Vaccines Oral Live Market Drivers
12.2 Cholera Vaccines Oral Live Market Restraints
12.3 Cholera Vaccines Oral Live Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Cholera Vaccines Oral Live and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cholera Vaccines Oral Live
13.3 Cholera Vaccines Oral Live Production Process
13.4 Cholera Vaccines Oral Live Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cholera Vaccines Oral Live Typical Distributors
14.3 Cholera Vaccines Oral Live Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Cholera Vaccines Oral Live Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cholera Vaccines Oral Live Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. PaxVax Basic Information, Manufacturing Base and Competitors
Table 4. PaxVax Major Business
Table 5. PaxVax Cholera Vaccines Oral Live Product and Services
Table 6. PaxVax Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. PaxVax Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Cholera Vaccines Oral Live Product and Services
Table 11. Sanofi Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Recent Developments/Updates
Table 13. Valneva Basic Information, Manufacturing Base and Competitors
Table 14. Valneva Major Business
Table 15. Valneva Cholera Vaccines Oral Live Product and Services
Table 16. Valneva Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Valneva Recent Developments/Updates
Table 18. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 19. EuBiologics Major Business
Table 20. EuBiologics Cholera Vaccines Oral Live Product and Services
Table 21. EuBiologics Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. EuBiologics Recent Developments/Updates
Table 23. Shanghai United Cell Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Shanghai United Cell Biotechnology Major Business
Table 25. Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Product and Services
Table 26. Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Shanghai United Cell Biotechnology Recent Developments/Updates
Table 28. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 29. Vabiotech Major Business
Table 30. Vabiotech Cholera Vaccines Oral Live Product and Services
Table 31. Vabiotech Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Vabiotech Recent Developments/Updates
Table 33. Global Cholera Vaccines Oral Live Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Cholera Vaccines Oral Live Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Cholera Vaccines Oral Live Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Cholera Vaccines Oral Live, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Cholera Vaccines Oral Live Production Site of Key Manufacturer
Table 38. Cholera Vaccines Oral Live Market: Company Product Type Footprint
Table 39. Cholera Vaccines Oral Live Market: Company Product Application Footprint
Table 40. Cholera Vaccines Oral Live New Market Entrants and Barriers to Market Entry
Table 41. Cholera Vaccines Oral Live Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Cholera Vaccines Oral Live Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Cholera Vaccines Oral Live Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Cholera Vaccines Oral Live Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Cholera Vaccines Oral Live Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Cholera Vaccines Oral Live Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Cholera Vaccines Oral Live Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Cholera Vaccines Oral Live Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Cholera Vaccines Oral Live Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Cholera Vaccines Oral Live Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Cholera Vaccines Oral Live Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Cholera Vaccines Oral Live Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Cholera Vaccines Oral Live Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Cholera Vaccines Oral Live Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Cholera Vaccines Oral Live Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Cholera Vaccines Oral Live Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Cholera Vaccines Oral Live Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Cholera Vaccines Oral Live Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Cholera Vaccines Oral Live Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Cholera Vaccines Oral Live Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Cholera Vaccines Oral Live Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Cholera Vaccines Oral Live Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Cholera Vaccines Oral Live Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Cholera Vaccines Oral Live Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Cholera Vaccines Oral Live Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Cholera Vaccines Oral Live Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Cholera Vaccines Oral Live Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Cholera Vaccines Oral Live Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Cholera Vaccines Oral Live Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Cholera Vaccines Oral Live Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Cholera Vaccines Oral Live Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Cholera Vaccines Oral Live Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Cholera Vaccines Oral Live Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Cholera Vaccines Oral Live Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Cholera Vaccines Oral Live Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Cholera Vaccines Oral Live Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Cholera Vaccines Oral Live Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Cholera Vaccines Oral Live Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Cholera Vaccines Oral Live Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Cholera Vaccines Oral Live Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Cholera Vaccines Oral Live Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Cholera Vaccines Oral Live Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Cholera Vaccines Oral Live Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Cholera Vaccines Oral Live Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Cholera Vaccines Oral Live Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Cholera Vaccines Oral Live Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Cholera Vaccines Oral Live Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Cholera Vaccines Oral Live Raw Material
Table 101. Key Manufacturers of Cholera Vaccines Oral Live Raw Materials
Table 102. Cholera Vaccines Oral Live Typical Distributors
Table 103. Cholera Vaccines Oral Live Typical Customers
Table 1. Global Cholera Vaccines Oral Live Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cholera Vaccines Oral Live Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. PaxVax Basic Information, Manufacturing Base and Competitors
Table 4. PaxVax Major Business
Table 5. PaxVax Cholera Vaccines Oral Live Product and Services
Table 6. PaxVax Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. PaxVax Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Cholera Vaccines Oral Live Product and Services
Table 11. Sanofi Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Recent Developments/Updates
Table 13. Valneva Basic Information, Manufacturing Base and Competitors
Table 14. Valneva Major Business
Table 15. Valneva Cholera Vaccines Oral Live Product and Services
Table 16. Valneva Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Valneva Recent Developments/Updates
Table 18. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 19. EuBiologics Major Business
Table 20. EuBiologics Cholera Vaccines Oral Live Product and Services
Table 21. EuBiologics Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. EuBiologics Recent Developments/Updates
Table 23. Shanghai United Cell Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Shanghai United Cell Biotechnology Major Business
Table 25. Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Product and Services
Table 26. Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Shanghai United Cell Biotechnology Recent Developments/Updates
Table 28. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 29. Vabiotech Major Business
Table 30. Vabiotech Cholera Vaccines Oral Live Product and Services
Table 31. Vabiotech Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Vabiotech Recent Developments/Updates
Table 33. Global Cholera Vaccines Oral Live Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Cholera Vaccines Oral Live Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Cholera Vaccines Oral Live Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Cholera Vaccines Oral Live, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Cholera Vaccines Oral Live Production Site of Key Manufacturer
Table 38. Cholera Vaccines Oral Live Market: Company Product Type Footprint
Table 39. Cholera Vaccines Oral Live Market: Company Product Application Footprint
Table 40. Cholera Vaccines Oral Live New Market Entrants and Barriers to Market Entry
Table 41. Cholera Vaccines Oral Live Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Cholera Vaccines Oral Live Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Cholera Vaccines Oral Live Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Cholera Vaccines Oral Live Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Cholera Vaccines Oral Live Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Cholera Vaccines Oral Live Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Cholera Vaccines Oral Live Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Cholera Vaccines Oral Live Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Cholera Vaccines Oral Live Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Cholera Vaccines Oral Live Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Cholera Vaccines Oral Live Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Cholera Vaccines Oral Live Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Cholera Vaccines Oral Live Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Cholera Vaccines Oral Live Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Cholera Vaccines Oral Live Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Cholera Vaccines Oral Live Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Cholera Vaccines Oral Live Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Cholera Vaccines Oral Live Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Cholera Vaccines Oral Live Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Cholera Vaccines Oral Live Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Cholera Vaccines Oral Live Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Cholera Vaccines Oral Live Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Cholera Vaccines Oral Live Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Cholera Vaccines Oral Live Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Cholera Vaccines Oral Live Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Cholera Vaccines Oral Live Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Cholera Vaccines Oral Live Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Cholera Vaccines Oral Live Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Cholera Vaccines Oral Live Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Cholera Vaccines Oral Live Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Cholera Vaccines Oral Live Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Cholera Vaccines Oral Live Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Cholera Vaccines Oral Live Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Cholera Vaccines Oral Live Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Cholera Vaccines Oral Live Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Cholera Vaccines Oral Live Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Cholera Vaccines Oral Live Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Cholera Vaccines Oral Live Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Cholera Vaccines Oral Live Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Cholera Vaccines Oral Live Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Cholera Vaccines Oral Live Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Cholera Vaccines Oral Live Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Cholera Vaccines Oral Live Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Cholera Vaccines Oral Live Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Cholera Vaccines Oral Live Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Cholera Vaccines Oral Live Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Cholera Vaccines Oral Live Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Cholera Vaccines Oral Live Raw Material
Table 101. Key Manufacturers of Cholera Vaccines Oral Live Raw Materials
Table 102. Cholera Vaccines Oral Live Typical Distributors
Table 103. Cholera Vaccines Oral Live Typical Customers
LIST OF FIGURES
Figure 1. Cholera Vaccines Oral Live Picture
Figure 2. Global Cholera Vaccines Oral Live Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cholera Vaccines Oral Live Consumption Value Market Share by Type in 2023
Figure 4. Euvichol- Plus Examples
Figure 5. DUKORAL Examples
Figure 6. Shanchol Examples
Figure 7. Others Examples
Figure 8. Global Cholera Vaccines Oral Live Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Cholera Vaccines Oral Live Consumption Value Market Share by Application in 2023
Figure 10. Prevention Examples
Figure 11. Emergency Response Examples
Figure 12. Global Cholera Vaccines Oral Live Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Cholera Vaccines Oral Live Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Cholera Vaccines Oral Live Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Cholera Vaccines Oral Live Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Cholera Vaccines Oral Live Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Cholera Vaccines Oral Live Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Cholera Vaccines Oral Live by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Cholera Vaccines Oral Live Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Cholera Vaccines Oral Live Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Cholera Vaccines Oral Live Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Cholera Vaccines Oral Live Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Cholera Vaccines Oral Live Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Cholera Vaccines Oral Live Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Cholera Vaccines Oral Live Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Cholera Vaccines Oral Live Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Cholera Vaccines Oral Live Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Cholera Vaccines Oral Live Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Cholera Vaccines Oral Live Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Cholera Vaccines Oral Live Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Cholera Vaccines Oral Live Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Cholera Vaccines Oral Live Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Cholera Vaccines Oral Live Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Cholera Vaccines Oral Live Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Cholera Vaccines Oral Live Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Cholera Vaccines Oral Live Consumption Value Market Share by Region (2019-2030)
Figure 54. China Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Cholera Vaccines Oral Live Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Cholera Vaccines Oral Live Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Cholera Vaccines Oral Live Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Cholera Vaccines Oral Live Market Drivers
Figure 75. Cholera Vaccines Oral Live Market Restraints
Figure 76. Cholera Vaccines Oral Live Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Cholera Vaccines Oral Live in 2023
Figure 79. Manufacturing Process Analysis of Cholera Vaccines Oral Live
Figure 80. Cholera Vaccines Oral Live Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Cholera Vaccines Oral Live Picture
Figure 2. Global Cholera Vaccines Oral Live Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cholera Vaccines Oral Live Consumption Value Market Share by Type in 2023
Figure 4. Euvichol- Plus Examples
Figure 5. DUKORAL Examples
Figure 6. Shanchol Examples
Figure 7. Others Examples
Figure 8. Global Cholera Vaccines Oral Live Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Cholera Vaccines Oral Live Consumption Value Market Share by Application in 2023
Figure 10. Prevention Examples
Figure 11. Emergency Response Examples
Figure 12. Global Cholera Vaccines Oral Live Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Cholera Vaccines Oral Live Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Cholera Vaccines Oral Live Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Cholera Vaccines Oral Live Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Cholera Vaccines Oral Live Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Cholera Vaccines Oral Live Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Cholera Vaccines Oral Live by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Cholera Vaccines Oral Live Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Cholera Vaccines Oral Live Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Cholera Vaccines Oral Live Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Cholera Vaccines Oral Live Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Cholera Vaccines Oral Live Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Cholera Vaccines Oral Live Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Cholera Vaccines Oral Live Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Cholera Vaccines Oral Live Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Cholera Vaccines Oral Live Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Cholera Vaccines Oral Live Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Cholera Vaccines Oral Live Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Cholera Vaccines Oral Live Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Cholera Vaccines Oral Live Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Cholera Vaccines Oral Live Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Cholera Vaccines Oral Live Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Cholera Vaccines Oral Live Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Cholera Vaccines Oral Live Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Cholera Vaccines Oral Live Consumption Value Market Share by Region (2019-2030)
Figure 54. China Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Cholera Vaccines Oral Live Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Cholera Vaccines Oral Live Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Cholera Vaccines Oral Live Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Cholera Vaccines Oral Live Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Cholera Vaccines Oral Live Market Drivers
Figure 75. Cholera Vaccines Oral Live Market Restraints
Figure 76. Cholera Vaccines Oral Live Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Cholera Vaccines Oral Live in 2023
Figure 79. Manufacturing Process Analysis of Cholera Vaccines Oral Live
Figure 80. Cholera Vaccines Oral Live Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
